Modified titanium materials, including TiO₂ and TiO₂-HA bioceramic coatings, were prepared by micro-arc oxidation and micro-arc oxidation-hydro-thermal methods. Determination of the hemocompatibility of the coatings through a hemolysis experiment, dynamic clotting time test, and platelet adhesion experiment was also performed. The results demonstrated that: Hemolysis rates of all samples were less than 5%, no hemolysis was observed. Compared with titanium and TiO₂ bioceramic coating of titanium, TiO₂-HA bioceramic coating of titanium exhibited lower hemolysis rate, slower change in dynamic clotting time and less platelet adherence. The proposed TiO₂-HA bioceramic coating further showed a lower degree of deformation, better inhibition of platelet aggregation and deformation, and excellent hemocompatibility.